CASTRATION-RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early cancer drug trial halted before full testing
Disease control TerminatedThis early-stage study tested a new oral drug called NUV-868, both alone and combined with two existing cancer medications (olaparib or enzalutamide), in adults with advanced solid tumors. The goal was to find safe doses and see if these treatments could help control cancers like…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that had stopped responding to hormone therapy, as well as other solid tumors. The trial aimed to see if the drug could slow cancer growth and shrink tumors. The study …
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC